D-0282-2025 Class II Ongoing

Recalled by FDC Limited — Aurangabad, Maharashtra State, N/A

FDA drug recall D-0282-2025 was initiated by FDC Limited on Mar 11, 2025 and is designated Class II. Reason for recall: Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle The recall status is ongoing. Affected quantity: 90960 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 26, 2025
Initiation Date
Mar 11, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
90960 bottles

Product description

Ciprofloxacin Ophthalmic Solution USP, 0.3% as base, package in 5 mL bottles, Rx Only, Distributed by: Leading Pharma LLC, Fairfield, NJ. Manufactured by: FDC Limited, Maharashtra, India, NDC 69315-308-05

Reason for recall

Defective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle

Distribution pattern

Nationwide in the U.S

Code information

Lot: 084A067, Exp 12/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0282-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0282-2025. Report a data issue: hello@regdatalab.com.